4 research outputs found
Controlled attenuation parameter-insulin resistance (CIR) score to predict non-alcoholic steatohepatitis
The diagnosis of non-alcoholic steatohepatitis (NASH) requires liver biopsy. Patients with NASH are at risk of progression to advanced fibrosis and hepatocellular carcinoma. A reliable non-invasive tool for the detection of NASH is needed. We aimed at developing a tool to diagnose NASH based on a predictive model including routine clinical and transient hepatic elastography (TE) data. All subjects undergoing elective cholecystectomy in our center were invited to participate, if alcohol intake was < 30 g/d for men and < 15 g/d for women. TE with controlled attenuation parameter (CAP) was obtained before surgery. A liver biopsy was taken during surgery. Multivariate logistic regression models to predict NASH were constructed with the first 100 patients, the elaboration group, and the results were validated in the next pre-planned 50 patients. Overall, 155 patients underwent liver biopsy. In the elaboration group, independent predictors of NASH were CAP value [adjusted OR (AOR) 1.024, 95% confidence interval (95% CI) 1.002-1.046, p = 0.030] and HOMA value (AOR 1.847, 95% CI 1.203-2.835, p < 0.001). An index derived from the logistic regression equation to identify NASH was designated as the CAP-insulin resistance (CIR) score. The area under the receiver operating characteristic curve (95%CI) of the CIR score was 0.93 (0.87-0.99). Positive (PPV) and negative predictive values (NPV) of the CIR score were 82% and 91%, respectively. In the validation set, PPV was 83% and NPV was 88%. In conclusion, the CIR score, a simple index based on CAP and HOMA, can reliably identify patients with and without NASH.J.M. is recipient of an intensification grant from Consejería de Salud, Junta de Andalucía (grant number: A1-0060-2021). J.A.P. is recipient of an intensification grant from the Instituto de Salud Carlos III (grant number: I3SNS). A.G.S. is recipient of a Miguel Servet Research Contract from the Instituto de Salud Carlos III (CP18/00146). A.C.G. has received a Río Hortega grant from the Instituto de Salud Carlos III (grant number CM19/00251) and a research extension grant from Acciones para el refuerzo con recursos humanos de la actividad investigadora en las Unidades Clínicas del Servicio Andaluz de Salud 2021, acción B (Clínico-Investigadores) (grant number B-0061-2021).This work has been partially funded by the Instituto de Salud Carlos III (grant no: PI18/00606); co-funded by ERDF "A way to make Europe" and Consejería de Salud de la Junta de Andalucía (PI-0001/2017).Peer reviewe
PEComa hepático: un tumor inusual en una localización infrecuente.
Perivascular epithelioid cell neoplasms (PEComas) are a tumor family defined as such just a couple of decades ago. They make an unusual group of neoplasms, which can appear in different locations of the organism. PEComas are usually considered to be benign tumors, but there are some histological features that make some subgroups suspicious of malignancy. The treatment of these tumors consist in their surgical resection, with no current effective complementary oncological treatment known. We present the clinical case of a woman that underwent surgery for a resection of a hepatic lesion labeled afterwards as a PEComa with malignant features
Endovascular treatment of iatrogenic hemobilia Tratamiento endovascular de hemobilia iatrogénica
Hepatic PEcoma: an unusual tumor in an infrequent location
Los tumores de células neoplásicas perivasculares epitelioides (PEComas) son una familia de tumoraciones caracterizada
apenas un par de décadas antes. Componen un grupo inusual de neoplasias, que puede aparecer en distintas localizaciones
del organismo. Por lo general, los PEComas se consideran tumores benignos, pero hay ciertas características histológicas
que hacen de algunos subgrupos lesiones sospechosas de una malformación maligna. El tratamiento de estos tumores
consiste en la resección quirúrgica, pero no existe tratamiento oncológico por completo eficaz. Se presenta el caso clínico
de una mujer sometida a la resección de una lesión hepática con diagnóstico posterior de PEComa con rasgos de proceso
malignoPerivascular epithelioid cell neoplasms (PEComas) are a tumor family defined as such just a couple of decades ago. They make an unusual group of neoplasms, which can appear in different locations of the organism. PEComas are usually considered to be benign tumors, but there are some histological features that make some subgroups suspicious of malignancy. The treatment of these tumors consist in their surgical resection, with no current effective complementary oncological treatment known. We present the clinical case of a woman that underwent surgery for a resection of a hepatic lesion labeled afterwards as a PEComa with malignant features